NASDAQ:PTE - Polarityte Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$14.34 -1.05 (-6.82 %)
(As of 02/17/2019 04:00 PM ET)
Previous Close$14.34
Today's Range$14.0150 - $15.59
52-Week Range$11.54 - $41.22
Volume404,956 shs
Average Volume217,438 shs
Market Capitalization$310.52 million
P/E Ratio-2.95
Dividend YieldN/A
Beta1.59
PolarityTE, Inc., a biotechnology and regenerative biomaterials company, focuses on discovering, designing, and developing a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine and Contract Services. It offers SkinTE, a tissue product for treatment of defects of the skin, as well as contract research services. The company also develops OsteoTE, an autologous homologous bone regeneration product; and CartTE, an autologous cartilage regeneration product. In addition, it develops AdipoTE to optimize the delivery of autologous fat; AngioTE for vascular regeneration; NeuralTE for peripheral nerve injuries of the extremities, as well as for patients with neuromas or chronic compression due to joint replacements, migraines, craniofacial injuries, carpal tunnel syndrome, and those who have undergone hernia or abdominal-based procedures; UroTE for the delivery of autologous urogenital epithelium and submucosa; LiverTE to address various causes of liver failure; and BowelTE to deliver an optimized autologous construct to aid in the regeneration of bowel tissue. PolarityTE, Inc. is headquartered in Salt Lake City, Utah.

Receive PTE News and Ratings via Email

Sign-up to receive the latest news and ratings for PTE and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Prepackaged software
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:PTE
CUSIPN/A
Phone385-237-2279

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.56 million
Book Value$3.80 per share

Profitability

Net Income$-65,440,000.00
Net Margins-4,259.44%

Miscellaneous

Employees123
Market Cap$310.52 million
OptionableOptionable

Polarityte (NASDAQ:PTE) Frequently Asked Questions

What is Polarityte's stock symbol?

Polarityte trades on the NASDAQ under the ticker symbol "PTE."

How were Polarityte's earnings last quarter?

Polarityte Inc (NASDAQ:PTE) posted its quarterly earnings data on Monday, January, 14th. The company reported ($0.96) earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of ($1.02) by $0.06. The firm had revenue of $1.13 million for the quarter, compared to the consensus estimate of $0.80 million. Polarityte had a negative return on equity of 258.52% and a negative net margin of 4,259.44%. View Polarityte's Earnings History.

When is Polarityte's next earnings date?

Polarityte is scheduled to release their next quarterly earnings announcement on Monday, March 18th 2019. View Earnings Estimates for Polarityte.

What price target have analysts set for PTE?

5 brokers have issued 1-year price targets for Polarityte's shares. Their forecasts range from $5.00 to $65.00. On average, they expect Polarityte's share price to reach $37.50 in the next twelve months. This suggests a possible upside of 161.5% from the stock's current price. View Analyst Price Targets for Polarityte.

What is the consensus analysts' recommendation for Polarityte?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Polarityte in the last year. There are currently 1 sell rating and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Polarityte.

What are Wall Street analysts saying about Polarityte stock?

Here are some recent quotes from research analysts about Polarityte stock:
  • 1. According to Zacks Investment Research, "PolarityTE, Inc. creates regenerative medicine and provides tissue engineering platform. It develops and obtains regulatory approval for technology which utilizes a patient's own tissue substrates for regeneration of skin, bone, muscle, cartilage and nerves. The product pipeline comprises SkinTE, OsteoTE, AngioTE, MyoTE, CarteTE, AdiposeTE and NeuralTE. PolarityTE, Inc., formerly known as Majesco Entertainment Company, is headquatered in Salt lake City, Utah. " (2/15/2019)
  • 2. Cantor Fitzgerald analysts commented, ": We reiterate our Overweight rating and $65 12-month price target on PolarityTE following 4Q18 (FY 10/31/2018) earnings. During the quarter, Polarity reported SkinTE revenues of $0.4 million (76% QoQ increase) and total revenues of $1.1 million (172% QoQ increase). Our focus for 2019 remains on the regional market release of SkinTE and limited market release of OsteoTE. We provide takeaways from the announcement and conference call below." (1/14/2019)

Has Polarityte been receiving favorable news coverage?

News articles about PTE stock have trended somewhat positive this week, according to InfoTrie Sentiment. The research group rates the sentiment of news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Polarityte earned a coverage optimism score of 1.4 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 1.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next few days.

Who are some of Polarityte's key competitors?

Who are Polarityte's key executives?

Polarityte's management team includes the folowing people:
  • Dr. Denver M. Lough, Chairman & CEO (Age 38)
  • Mr. Paul Elliot Mann, Chief Financial Officer
  • Dr. Edward Winslow Swanson, Chief Operating Officer (Age 34)
  • Mr. Nikolai Sopko, Chief Scientific Officer
  • Mr. Rich Haerle, VP of Investor Relations & Strategy

How do I buy shares of Polarityte?

Shares of PTE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Polarityte's stock price today?

One share of PTE stock can currently be purchased for approximately $14.34.

How big of a company is Polarityte?

Polarityte has a market capitalization of $310.52 million and generates $1.56 million in revenue each year. The company earns $-65,440,000.00 in net income (profit) each year or ($4.86) on an earnings per share basis. Polarityte employs 123 workers across the globe.

What is Polarityte's official website?

The official website for Polarityte is http://www.polarityte.com.

How can I contact Polarityte?

Polarityte's mailing address is 123 WRIGHT BROTHERS DRIVE, SALT LAKE CITY UT, 84116. The company can be reached via phone at 385-237-2279 or via email at [email protected]


MarketBeat Community Rating for Polarityte (NASDAQ PTE)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  31 (Vote Outperform)
Underperform Votes:  31 (Vote Underperform)
Total Votes:  62
MarketBeat's community ratings are surveys of what our community members think about Polarityte and other stocks. Vote "Outperform" if you believe PTE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PTE will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/17/2019 by MarketBeat.com Staff

Featured Article: Conference Calls

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel